17. 多系統萎縮症 Multiple system atrophy Clinical trials / Disease details

臨床試験数 : 118 / 薬物数 : 163 - (DrugBank : 49) / 標的遺伝子数 : 61 - 標的パスウェイ数 : 112

2 trials found

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	EUCTR2009-016377-15-IT (EUCTR)	26/10/2009	26/10/2009	DOUBLE-BLIND, PLACEBO-CONTROLLED, RANDOMIZED TRIAL TO TEST THE EFFICACY, SAFETY AND TOLERABILITY OF LITHIUM IN MULTIPLE SYSTEM ATROPHY - Lithium in MSA	DOUBLE-BLIND, PLACEBO-CONTROLLED, RANDOMIZED TRIAL TO TEST THE EFFICACY, SAFETY AND TOLERABILITY OF LITHIUM IN MULTIPLE SYSTEM ATROPHY - Lithium in MSA	Muliple system atrophy MedDRA version: 9.1;Level: HLT;Classification code 10008028	Trade Name: LITIO CARBONATO INN or Proposed INN: LITHIUM CARBONATE	UNIVERSITA` DEGLI STUDI DI NAPOLI FEDERICO II	NULL	Authorised-recruitment may be ongoing or finished			Female: yes Male: yes			Italy
2	NCT00997672 (ClinicalTrials.gov)	October 2009	16/10/2009	Lithium in Multiple System Atrophy	A Double-blind, Randomized, Placebo-controlled Clinical Trial to Assess Efficacy, Safety and Tolerability of Lithium in Multiple System Atrophy.	Multiple System Atrophy	Drug: Lithium Carbonate;Drug: Placebo	Federico II University	NULL	Terminated	18 Years	80 Years	All	10	Phase 2	Italy